Market Trends of Asia Pacific Pharmaceutical Blister Packaging Industry
The Aging Population and the Prevalence of Diseases are Expected to Drive Market Growth
- The Asia-Pacific region is undergoing profound population changes. All countries in the region are aging at an exceptional pace, although the timing and speed of this transition vary across the region. According to the United Nations ESCAP, in 2016, about 12.4% of the population in the area was 60 years or older; this is projected to grow to 1.3 billion people by 2050.
- The infectious disease hindrance remains substantial in countries owing to the presence of low and lower-middle-income groups, while mortality and morbidity associated with ignored tropical diseases, HIV infection, tuberculosis, and malaria remain elevated. Moreover, deaths from emerging and re-emerging infections, compared to seasonal and endemic conditions, have continued throughout the twenty-first century. This points to a possible new era of infectious disease, defined by outbreaks of emerging, re-emerging, and endemic pathogens that spread quickly, aided by global connectivity and shifted ranges owing to climate change.
- According to a study by the National Center for Biotechnology Information (NCBI), non-communicable diseases (NCDs) lead to significant mortality and morbidity. The common NCDs are cardiovascular diseases (CVD), diabetes, cancer, and chronic respiratory diseases. NCD-related deaths in Asia-Pacific have increased; NCDs are the primary cause of deaths and disease burden in the region.
- According to the National Bureau of Statistics of China, the population above 64 was 15.4% in 2023, an increase from 13.5% in 2020. Companies operating in the region are encouraged to develop independent research and development teams to investigate cutting-edge, environmentally friendly, secure, helpful, and sustainable blister packaging.
- AstraZeneca declared plans to build a production facility for its regional headquarters in Qingdao, Shandong. China is the company's second-largest market after the United States. AstraZeneca will continue to increase its confidence in investing in China to encourage the growth of Qingdao's biopharmaceutical industry and support the National Health Vision 2030.
Understand The Key Trends Shaping This Market
Download PDF
India is Expected to Witness Growth Due to the Rising Population
- The increasing market for safety and protection to boost product longevity is an essential factor fueling the growth of the blister packaging market. Government initiatives to improve medical facilities will further drive market growth in India. For instance, the Pradhan Mantri Ayushman Bharat - Health Infrastructure Mission (PM-ABHIM) is one of the government's significant pan-India infrastructure projects to boost the country's health infrastructure, surveillance, and health research.
- In addition, the government has designed the Free Diagnostics Service Initiative to cut direct healthcare costs and out-of-pocket charges. The rise in disposable income is a significant factor projected to promote India's pharmaceutical packaging market expansion.
- The pharmaceutical blister packaging market is fueled by population growth, urbanization, and changing consumer preferences. According to UN estimates, India surpassed China as the most populous country in 2023. Also, according to the International Monetary Fund (IMF), the total estimated population in 2024 is expected to reach 1,441.72 million, an increase from 1,396.39 million in 2020.
- Pharmaceutical manufacturers are focusing on delivering more granular information on pharmaceutical blister products. With additional sophisticated serialization of prescription and non-prescription pharmaceuticals, the healthcare sector can guarantee that the medicine is not counterfeit and that the right patient gets the correct dose and medication at the right time. 2D code that contains product, dose, batch code, and expiry date information on individual blister packs, or even coding each pocket containing a tablet, can help lower the number of cases where patients unintentionally obtain the wrong medicine or dose.
- According to a study by A.P. Moller-Maersk in February 2024, India's pharmaceutical supply chain underwent significant transformation spurred by globalization, technological advancements, regulatory shifts, and rising healthcare product demand. The focus shifted from manual and transactional methods to automation and strategic innovation. Such transformation in the pharmaceutical sector would further boost the market for blister packaging.
Get Analysis on Important Geographic Markets
Download PDF
